Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2025 21:15 ET | Source: NeuroPace, Inc

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced...
May 08, 2024 16:05 ET | Source: NeuroPace, Inc

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update

-- Revenue increased to $18.1 million in Q1 2024, a 25% increase over Q1 2023 -- -- Extended the maturity date of the Company’s term loan by one year to September 30, 2026 -- -- Maintained full-year...
March 27, 2024 16:05 ET | Source: NeuroPace, Inc

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

MOUNTAIN VIEW, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced...
February 15, 2024 16:05 ET | Source: NeuroPace, Inc

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

MOUNTAIN VIEW, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
January 08, 2024 07:03 ET | Source: NeuroPace, Inc

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

Preliminary unaudited revenue expected to be between $17.5 million and $18.0 million for Q4 2023 and between $64.9 million and $65.4 million for full year 2023 Company begins 2024 with cash balance...